Determination of Regulatory Review Period for Purposes of Patent Extension; AGILI–C
The Food and Drug Administration FDA or the Agency has determined the regulatory review period for AGILI-C and is publishing this notice of that determination as required by law. FDA …
Agency Information Collection Activities; Proposals, Submissions, and Approvals
In compliance with the
Implementation of HAVANA Act
This rule implements the HAVANA Act of 2021 the Act for the U.S. Department of Agriculture USDA. The Act provides the authority for the Secretary of Agriculture and other agency …
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The Food and Drug Administration FDA or Agency is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on among other things …
The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …
Evaluation of Stakeholder Training and Program Support
Request for Information: Efforts by Certain Foreign Countries to Eliminate the Worst Forms of Child Labor; Child Labor, Forced Labor, and Forced or Indentured Child Labor in the Production of Goods in Foreign Countries; and Business Practices to Reduce the Likelihood of Forced Labor or Child Labor in the Production of Goods
This notice is a request for information andor comment on three reports issued by the Bureau of International Labor Affairs ILAB regarding child labor and forced labor in certain foreign …
Part D Coordination of Benefits Data (CMS-10171)
(CMS-10341) Section 1115 Demonstration Projects Regulations
The Centers for Medicare Medicaid Services CMS is announcing
(CMS-10875) Reporting Requirements and Corrective Action Plans Under Section 1902(tt) of the Social Security Act
Request For Enrollment in Supplementary Medical Insurance (CMS-4040)
Application For Medicare Part A and Part B Special Enrollment Period (Exceptional Circumstances) (CMS-10797)
Application for Enrollment in Medicare the Medical Insurance Program (CMS-40B)
(CMS-224-14) Federally Qualified Health Center Cost Report Form
Pre-Market Animal Food Ingredient Review Programs; Request for Comments
The Food and Drug Administration FDA we or Agency is soliciting comments from the public regarding the Food Additive Petition and Generally Recognized as Safe GRAS Notification programs to determine …
CMS Plan Benefit Package (PBP) and Formulary CY 2026 (CMS-R-262)
Digital Health Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Total Product Lifecycle Considerations for Generative Artificial Intelligence-Enabled Medical Devices
The Food and Drug Administration FDA announces a forthcoming public advisory committee meeting of the Digital Health Advisory Committee the Committee. The general function of the Committee is to provide …